Crypto
XRP Loses All Profits Made After Victory Against SEC
XRP’s faltering fortunes are a stark reminder of the connection between litigation and cryptocurrency valuations. While the market continues to grapple with regulatory challenges, the impact of legal decisions on token values highlights the complex relationship between the legal framework and the digital asset ecosystem. According to the latest data, XRP is trading at the 50-cent mark.
The prevailing bearish sentiment in the broader cryptocurrency market has cast a shadow over tokens that could have otherwise thrived due to robust fundamental factors. Traders are currently opting to capitalize on price fluctuations by locking in profits rather than pursuing a long-term buy-and-hold strategy.
XRP, a major player in the cryptocurrency space in terms of market capitalization, has been unable to escape the impact of this market downturn. This high-profile altcoin has suffered a significant drop in value following Ripple Labs’ heavy litigation against the U.S. Securities and Exchange Commission (SEC) in July.
According to the latest data, XRP is trading at the 50-cent mark, down 14% over the past week and down 30% in 30 days. A closer look at the price chart data highlights this volatility; On July 20, the token reached 83 cents, its highest value in a year. However, on Wednesday, the current price levels dropped back to the levels before the SEC’s decision.
Read more about the price of XRP and read the latest business news of the day with the Born2Invest mobile app.
This decline in XRP prices highlights the impact of the SEC’s legal action against Ripple in 2020
The regulator filed a lawsuit against Ripple, alleging that the company sold unregistered securities. It is important to note that Ripple has historically maintained a distinction between itself and XRP, the token underlying various products and the XRP ledger network. Nevertheless, developments in the litigation have had a noticeable impact on the value of XRP.
In July 2023, a pivotal moment occurred when a U.S. judge ruled that the sale of XRP tokens on exchanges was not equivalent to investment contracts. The ruling effectively put on hold a legal battle that had been one of the most protracted and contentious in the cryptocurrency landscape.
XRP’s faltering fortunes are a stark reminder of the connection between litigation and cryptocurrency valuations. While the market continues to grapple with regulatory challenges, the impact of legal decisions on token values highlights the complex relationship between the legal framework and the digital asset ecosystem.
The XRP case exemplifies how a single court decision can dramatically impact a cryptocurrency’s performance and highlights the need for investors and industry participants to closely monitor regulatory developments that may impact market dynamics.
__
(Featured image by Rūdolfs Klintsons via Pexels)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Coin Kurier. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech1 week ago
Vytrus Biotech Reports Its Best Quarter: Record Revenue and Rising EBITDA
-
Cannabis2 weeks ago
Ireland: Legislative Committee Calls for Legalization of Cannabis and Decriminalization of Drugs
-
Biotech6 days ago
Dijon Biotech Company Inventiva Raises 348 Million to Complete Its Phase III
-
Business2 weeks ago
The TopRanked.io Weekly Digest: What’s Hot in Affiliate Marketing [CryptoTab Affiliate Program]